BRIEF—Chiesi expands Trimbow label in Europe

Chiesi has successfully expanded the label for Trimbow (BDP/FF/G) in Europe, recognising its effect on exacerbations and symptoms in people with moderate to severe chronic obstructive pulmonary disease (COPD).

The treatment was tested on people who were not adequately treated with dual bronchodilation or with an inhaled corticosteroid and a LABA.

Europe head Alessandro Chiesi said: “We are delighted that Trimbow is now available for patients with moderate to severe COPD requiring a step up from dual bronchodilation.”

The label update is based on data from the TRIBUTE study.